The global cartilage repair market accounted for USD 1.37 billion in 2023 and is expected to reach at USD 7.87 billion by 2034 with a CAGR of 17.23% during the forecast period 2024-2034. The market will grow as a result of factors such as rising sports injuries and active lifestyles, growing demand for minimally invasive procedures, increasing incidence of bone and joint disorders, and government funding and support.
The most prevalent long-term joint ailment and a significant factor driving the cartilage repair industry is osteoarthritis (OA). The growing number of elderly people, the increasing effects of obesity, and other lifestyle risk factors are all contributing causes to the increasing prevalence of osteoarthritis (OA). The number of persons with OA and other joint problems is predicted to climb sharply as the population ages, creating a greater need for cartilage restoration methods. For instance, in 2022, it was projected that 4.74 million Australians over 50 had osteoporosis or osteopenia, which was responsible for 1.8 million DALYs (disability-adjusted life years). A measure of the total burden of disease that accounts for both death and disability is called DALYs.
By type, the cell-based therapies segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the increasing efficacy of regenerative treatments and rising adoption of advanced medical technologies. For instance, Smith & Nephew plc introduced their NEXT GENERATION InStride Posterior Cruciate Ligament (PCL) System in the United States in 2023. This minimally invasive procedure is intended for PCL rebuilding in the event of knee trauma. Additionally, the non-cell-based therapies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for minimally invasive treatments and advancements in biomaterial technologies.
By application, the hyaline cartilage repair segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the high prevalence of joint disorders and continuous advancements in repair techniques. For instance, in 2022, the US FDA granted Zimmer Biomet Holdings, Inc. 510(k) clearance for its AMYKOS® Osteochondral Autograft Transfer System (OATS). This method makes knee cartilage repair treatments less intrusive.
By treatment type, the intrinsic repair stimulus segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the natural healing capabilities it leverages and increasing adoption of biologic treatments. For instance, in 2023, IVericel Corporation announced that it will be working with Allergan to develop and market Carticel® autologous chondrocyte implantation, which is intended to correct abnormalities in facial cartilage. Additionally, the palliative segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for pain management solutions and minimally invasive procedures.
By site, the knee segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the high incidence of knee injuries and osteoarthritis, along with advancements in knee repair techniques. For instance, at the Orthopaedic Learning Center (OLC) Annual Meeting, CONMED Corporation (2024) presented encouraging clinical data from its current trial assessing the effectiveness of its CONTOUR® Cartilage Restoration System. Additionally, the ankle and foot segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of sports injuries and advancements in treatment options for these areas.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the availability of advanced medical equipment and a high volume of surgical procedures performed. For instance, in 2023, Anika Therapeutics, Inc. expanded its commercial footprint for its Hyaluronic Acid (HA) viscosupplementation product, Monovisc®, in numerous new regions around Asia Pacific. Additionally, the ambulatory surgery centers and clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for outpatient procedures and cost-effective treatment options.
North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of advanced healthcare infrastructure, high prevalence of joint disorders, and strong research and development activities. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising healthcare expenditure, increasing awareness about advanced treatment options, and expanding access to healthcare services. For instance, in 2022, Stryker Corporation acquired Incus Surgical, a firm pioneering novel technology for cartilage repair, including their CartiHeal® allograft implant.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The most prevalent long-term joint ailment and a significant factor driving the cartilage repair industry is osteoarthritis (OA). The growing number of elderly people, the increasing effects of obesity, and other lifestyle risk factors are all contributing causes to the increasing prevalence of osteoarthritis (OA). The number of persons with OA and other joint problems is predicted to climb sharply as the population ages, creating a greater need for cartilage restoration methods. For instance, in 2022, it was projected that 4.74 million Australians over 50 had osteoporosis or osteopenia, which was responsible for 1.8 million DALYs (disability-adjusted life years). A measure of the total burden of disease that accounts for both death and disability is called DALYs.
By type, the cell-based therapies segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the increasing efficacy of regenerative treatments and rising adoption of advanced medical technologies. For instance, Smith & Nephew plc introduced their NEXT GENERATION InStride Posterior Cruciate Ligament (PCL) System in the United States in 2023. This minimally invasive procedure is intended for PCL rebuilding in the event of knee trauma. Additionally, the non-cell-based therapies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for minimally invasive treatments and advancements in biomaterial technologies.
By application, the hyaline cartilage repair segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the high prevalence of joint disorders and continuous advancements in repair techniques. For instance, in 2022, the US FDA granted Zimmer Biomet Holdings, Inc. 510(k) clearance for its AMYKOS® Osteochondral Autograft Transfer System (OATS). This method makes knee cartilage repair treatments less intrusive.
By treatment type, the intrinsic repair stimulus segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the natural healing capabilities it leverages and increasing adoption of biologic treatments. For instance, in 2023, IVericel Corporation announced that it will be working with Allergan to develop and market Carticel® autologous chondrocyte implantation, which is intended to correct abnormalities in facial cartilage. Additionally, the palliative segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for pain management solutions and minimally invasive procedures.
By site, the knee segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the high incidence of knee injuries and osteoarthritis, along with advancements in knee repair techniques. For instance, at the Orthopaedic Learning Center (OLC) Annual Meeting, CONMED Corporation (2024) presented encouraging clinical data from its current trial assessing the effectiveness of its CONTOUR® Cartilage Restoration System. Additionally, the ankle and foot segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of sports injuries and advancements in treatment options for these areas.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global cartilage repair market in 2023 owing to the availability of advanced medical equipment and a high volume of surgical procedures performed. For instance, in 2023, Anika Therapeutics, Inc. expanded its commercial footprint for its Hyaluronic Acid (HA) viscosupplementation product, Monovisc®, in numerous new regions around Asia Pacific. Additionally, the ambulatory surgery centers and clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for outpatient procedures and cost-effective treatment options.
North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of advanced healthcare infrastructure, high prevalence of joint disorders, and strong research and development activities. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising healthcare expenditure, increasing awareness about advanced treatment options, and expanding access to healthcare services. For instance, in 2022, Stryker Corporation acquired Incus Surgical, a firm pioneering novel technology for cartilage repair, including their CartiHeal® allograft implant.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Application, Treatment Type, Site, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Cartilage Repair Market Report 2023 - 2034
Cartilage Repair Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Cell-Based
- Chondrocyte Transplantation
- Growth Factor Technology
- Non-Cell-Based
- Tissue Scaffolds
- Cell-Free Composites
Cartilage Repair Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Hyaline
- Fibrocartilage
Cartilage Repair Market Analysis & Forecast by Treatment Type 2023 - 2034 (Revenue USD Bn)
- Palliative
- Viscosupplementation
- Debridement & Lavage
- Intrinsic Repair Stimulus
Cartilage Repair Market Analysis & Forecast by Site 2023 - 2034 (Revenue USD Bn)
- Knee
- Hip
- Ankle and Foot
- Other Application Sites
Cartilage Repair Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgery Centres
- Clinics
Cartilage Repair Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cartilage Repair Market: Type Estimates & Trend Analysis
8. Cartilage Repair Market: Application Estimates & Trend Analysis
9. Cartilage Repair Market: Treatment Type Estimates & Trend Analysis
10. Cartilage Repair Market: Site Estimates & Trend Analysis
11. Cartilage Repair Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America Cartilage Repair Market
14. Europe Global Cartilage Repair Market
15. Asia Pacific Global Cartilage Repair Market
16. Latin America Global Cartilage Repair Market
17. MEA Global Cartilage Repair Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- Smith & Nephew plc
- Zimmer Biomet Holdings Inc.
- Vericel Corporation
- CONMED Corporation
- Anika Therapeutics Inc.
- Stryker Corporation
- DePuy Synthes (Johnson & Johnson)
- Arthrex Inc.
- Collagen Solutions plc
- BioTissue AG (a subsidiary of Zimmer Biomet)
- Histogenics Corporation
- MEDIPOST Co. Ltd.
- Orthocell Limited
- Osiris Therapeutics Inc.
- CartiHeal Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.37 Billion |
| Forecasted Market Value ( USD | $ 7.87 Billion |
| Compound Annual Growth Rate | 17.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
